AMMF’s Hybrid 2023 European Cholangiocarcinoma Conference
All presentations from AMMF’s 3-day European Cholangiocarcinoma Conference held 10-12 May 2023 are now available here to watch again. Simply click on the topic title to see that presentation.
| Topic | Presenter |
|---|---|
| WELCOME DAY THREE | |
| Welcome to Day 3 | Professor John Bridgewater Professor Lorenza Rimassa |
| CCA SPECIALIST GROUP UPDATES | |
| ENS–CCA – Overview and update | Dr Chiara Braconi Chair – ENS-CCA |
| CCA-UK – Overview and update | Professor Shahid A Khan Chair – CCA-UK |
| Question time | Panel |
| BIG DATA | |
| Introduction to Session | Dr Shirin Elizabeth Khorsandi Kings College, London Dr Tim Kendall University of Edinburgh |
| Molecular data: Implications of genomics in cholangiocarcinoma | Professor Jesper B Andersen University of Copenhagen, Denmark |
| How can AI inform physician’s decisions? | Professor Julien Calderaro Henri Mondor University Hospital, France |
| Exploring Protein Kinase CK2 inhibition and identifying new targets | Professor Kevin Gaston University of Nottingham |
| Question time | Panel |
| NOVEL FINDINGS IN CCA RESEARCH | |
| The role of normal cholangiocytes in regulating cholangiocarcinoma cells during co-culture | Gemma Owen University of Oxford |
| KLF5 upregulation is a common event in cholangiocarcinoma, acting as an oncogene and constituting a bad prognostic factor | Dr Pedro M. Rodrigues Biodonostia Health Research Institute, Spain |
| A Notch signalling niche drives the initiation and early growth of cholangiocarcinoma | Dr Anabel Martinez Lyons University Of Edinburgh |
| Question Time | Panel |
| Patient Perspective | Francesca Clementi |
| TRANSLATION INTO CLINICAL PRACTICE | |
| The ENSCCA clinical database: current status, studies and new results | Professor Jesus Bañales Biodonostia Institute, Spain |
| Biomarkers from the BILCAP series: Focus on HER2 | Dr Valerie Crolley University College Hospital London |
| Acquired resistance to FGFR inhibitors | Dr Daniel DiToro Brigham and Women’s Hospital, Boston |
| Question Time | Panel |
| WORKSHOP ON PRECLINICAL MODELS | |
| Characterisation of A Precision Cut Tumour Slice Model to Explore cholangiocarcinoma | Dr Laura Randle Liverpool John Moores University and The University of Liverpool |
| Novel genetically engineered mouse models of cholangiocarcinoma | Professor Jen Morton Cancer Research UK Beatson Institute |
| Question time | Panel |
| Conference highlights | Professor John Bridgewater Professor Lorenza Rimassa |
